OCEL (OCEL) Stock Price, News & Analysis

Name: OCEL (OCEL) Financial Data & Stock Overview
Creator: Stock Titan
License: https://www.stocktitan.net/terms-of-use

OCEL OTC

Company Description

OCEL (OTC: OCEL) is classified in the research and development in biotechnology industry within the Professional, Scientific, and Technical Services sector.

This page collects what Stock Titan holds for OCEL, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

Latest News

View All

November 27, 2023

-11.46%

Organicell Announces 1-for-200 Reverse Stock Split

stock split

July 26, 2023

+2.63%

Organicell Reports Interim Results of Phase 1/2A Research Program

clinical trial

June 29, 2023

+1.01%

Organicell Welcomes Howard Golub, MD, PhD As Its New EVP/CSO

June 21, 2023

+5.26%

Organicell Welcomes Harry Leider, MD, MBA as its New CEO

management

November 17, 2022

+22.78%

Organicell Starts Enrolling Long COVID Trial

covid-19

November 15, 2022

+35.34%

Organicell Activates COPD Trial at Mayo Clinic

OCEL has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include stock split, clinical trial, management, covid-19, partnership. View all OCEL news →

SEC Filings

View All

No SEC filings available for OCEL.

Financial Highlights

—

Revenue (latest FY)

—

Net Income (latest FY)

—

Diluted EPS (latest FY)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

OCEL Company Profile & Sector Positioning

OCEL (OCEL) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the OTC.